And they delayed the ASX announcement until today deliberately so that it coincided with the annual world symposium for lysosomal diseases.
The few results releases today indicate the research outcomes are not worthy of progressing it forward with PAR shareholder's money. Very disappointing and possibly not much better than some paracetamol and neurofen mixed together for mps VI sufferers.
Very disappointing. I'm still suscipious of the effectiveness of iPPS in OA....why havent they published in a peer-reviewed journal yet? Something smells bad.
And they delayed the ASX announcement until today deliberately...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
-0.010(4.08%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 26.0¢ | 23.0¢ | $317.0K | 1.319M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 49998 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 16000 | 2 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
23.5¢ |
Change
-0.010 ( 6.00 %) |
||||
| Open | High | Low | Volume | ||
| 25.0¢ | 26.0¢ | 23.0¢ | 531376 | ||
| Last updated 15.58pm 06/05/2024 ? | |||||
| PAR (ASX) Chart |